{
    "title": "Case report: A therapeutic attempt to treat Morbihan disease with Baricitinib.",
    "doc_id": "39170252",
    "writer": "Chen L",
    "year": "2024",
    "summary": "To our knowledge, this is the first study to use Baricitinib in Morbihan disease, although JAK inhibitors have already been successfully used before. It is hoped that our case report will provide new treatment options for Morbihan disease therapy....",
    "abstract": "A woman in her thirties who had been diagnosed with Morbihan disease did not notice a significant improvement in her condition after receiving years of treatment. Our decision to use Baricitinib helped her to achieve a better outcome. To our knowledge, this is the first study to use Baricitinib in Morbihan disease, although JAK inhibitors have already been successfully used before. It is hoped that our case report will provide new treatment options for Morbihan disease therapy.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/39170252/",
    "clean_text": "case report a therapeutic attempt to treat morbihan disease with baricitinib to our knowledge this is the first study to use baricitinib in morbihan disease although jak inhibitors have already been successfully used before it is hoped that our case report will provide new treatment options for morbihan disease therapy a woman in her thirties who had been diagnosed with morbihan disease did not notice a significant improvement in her condition after receiving years of treatment our decision to use baricitinib helped her to achieve a better outcome to our knowledge this is the first study to use baricitinib in morbihan disease although jak inhibitors have already been successfully used before it is hoped that our case report will provide new treatment options for morbihan disease therapy"
}